Drug Trial Radar · NCT00861705
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Last checked: Nov 19, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
454
Actual
Start
Jul 21, 2009
Primary completion
Aug 1, 2014
Study completion Sep 2, 2025
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Mar 13, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Factorial
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase II trial studies how well paclitaxel with or without carboplatin and/or bevacizumab followed by doxorubicin and cyclophosphamide works in treating patients with breast cancer that can be removed by surgery. Drugs used in chemotherapy, such as paclitaxel, carboplatin, doxorubicin, and cyclophosphamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Bevacizumab may stop the growth of tumor cells by blocking blood flow to the tumor. Giving chemotherapy together with bevacizumab before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.
Conditions
- Male Breast Carcinoma
- Stage IIA Breast Cancer AJCC v6 and v7
- Stage IIB Breast Cancer AJCC v6 and v7
- Stage IIIA Breast Cancer AJCC v7
- Triple-Negative Breast Carcinoma
Interventions
BevacizumabBiological
Given IV
CarboplatinDrug
Given IV
CyclophosphamideDrug
Given IV
Doxorubicin HydrochlorideDrug
Given IV
Laboratory Biomarker AnalysisOther
Correlative studies
PaclitaxelDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pathologic Complete Response (pCR) in the Breast. Defined as the Absence of Residual Invasive Carcinoma in the Breast (ypT0/is).Time frame: At the time of definitive surgical removal, up to 28 weeks
- Pathologic Complete Response (pCR) in the Breast. Defined as the Absence of Residual Invasive Carcinoma in the Breast (ypT0/is).Time frame: At the time of definitive surgical removal, up to 28 weeks
Locations
448 sites in 1 country. Site status is shown where the registry gives one.
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas
NEA Baptist Memorial Hospital
Jonesboro, Arkansas
Highlands Oncology Group - Rogers
Rogers, Arkansas
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Mills-Peninsula Medical Center
Burlingame, California
East Bay Radiation Oncology Center
Castro Valley, California
Eden Hospital Medical Center
Castro Valley, California
Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California
City of Hope Comprehensive Cancer Center
Duarte, California
Bay Area Breast Surgeons Inc
Emeryville, California
Epic Care Partners in Cancer Care
Emeryville, California
Valley Medical Oncology Consultants-Fremont
Fremont, California
Contra Costa Regional Medical Center
Martinez, California
El Camino Hospital
Mountain View, California
Palo Alto Medical Foundation-Camino Division
Mountain View, California
Sutter Cancer Research Consortium
Novato, California
Wilma Chan Highland Hospital
Oakland, California
Alta Bates Summit Medical Center - Summit Campus
Oakland, California
Bay Area Tumor Institute
Oakland, California
Hematology and Oncology Associates-Oakland
Oakland, California
Tom K Lee Inc
Oakland, California
Saint Joseph Hospital - Orange
Orange, California
Desert Regional Medical Center
Palm Springs, California
Palo Alto Medical Foundation Health Care
Palo Alto, California
Valley Care Health System - Pleasanton
Pleasanton, California
Valley Medical Oncology Consultants
Pleasanton, California
Salinas Valley Memorial
Salinas, California
California Pacific Medical Center-Pacific Campus
San Francisco, California
Doctors Medical Center- JC Robinson Regional Cancer Center
San Pablo, California
Breastlink Medical Group Inc
Santa Ana, California
Sutter Pacific Medical Foundation
Santa Rosa, California
Sutter Solano Medical Center/Cancer Center
Vallejo, California
The Medical Center of Aurora
Aurora, Colorado
Boulder Community Foothills Hospital
Boulder, Colorado
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado
AdventHealth Porter
Denver, Colorado
Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado
Saint Joseph Hospital - Cancer Centers of Colorado
Denver, Colorado
Rose Medical Center
Denver, Colorado
Showing 40 of 448 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.